FOR IMMEDIATE RELEASE
Arlington, TX (February 9, 2021) – Crosstree, a distinguished boutique investment bank focused exclusively on the needs of middle-market companies within the Pharmaceutical Services sector, has named 2M Clinical, LLC as one of the most innovative companies and thought leaders in the life sciences industry.
2M Clinical is an African-American owned CRO/consulting company whose mission is to drive positive health outcomes for all patients regardless of race, age, sex, gender, geography, or socioeconomic status. Featured in Crosstree’s publication Innovations in Pharmaceutical Development, 2M Clinical has been recognized for its groundbreaking use of GIS mapping technology and spatial epidemiology to support clinical trials for global CROs, sponsors, and patient advocacy groups. This technology, coupled with 2M’s expert clinical staff and data driven community outreach and patient recruitment, has catapulted the company to becoming the partner of choice for clinical studies that require hard to reach populations.
2M Clinical co-founder and CEO, Dr. Marcus Martin, founded the company in 2011 with his wife, Dr. Eddilisa Martin. “We are honored to be featured in Crosstree’s publication as an innovator and thought leader in the life sciences Industry. For a decade, 2M has worked tirelessly to promote health equity through our clinical expertise, innovative use of technology, and boots-on-the-ground community engagement,” Dr. Eddilisa Martin explains, “We are committed to supporting and managing cutting-edge clinical research and including underserved patient populations in these studies.”
Dr. Craig Reist, VP & Chief Scientific Officer at 2M Clinical adds, “This recognition is a testament to the hard work our team does for clients around the world. We look forward to expanding our reach within the pharmaceutical community and providing state-of-the-art care to patients in need.”
About 2M Clinical, LLC
2M Clinical, a division of 2M Research, is a minority-owned SBA 8(a)- and HUBZone-certified CRO and professional services firm. It provides quality, cost-effective, and timeline driven clinical trial services for pharmaceutical and medical device companies around the world. Its team has the knowledge, expertise, and hands-on experience to manage Phase I-IV domestic and international clinical trials, health services research, epidemiologic studies and bespoke consulting services surrounding clinical trial diversity and reimbursement and market access.